Skip to main navigation
Skip to search
Skip to main content
Ben-Gurion University Research Portal Home
Help & FAQ
Link opens in a new tab
Search content at Ben-Gurion University Research Portal
Home
Profiles
Research output
Research units
Prizes
Press/Media
Student theses
Projects
Activities
Datasets
Research Labs
Price trajectory of individual cancer drugs following launch
Noa Gordon
, Salomon M. Stemmer
,
Dan Greenberg
, Daniel A. Goldstein
Department of Health Policy and Management
Research output
:
Contribution to journal
›
Meeting Abstract
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Price trajectory of individual cancer drugs following launch'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Inflation
100%
Cancer Drugs
100%
Price Change
80%
Drug Costs
60%
United States
20%
Medicaid
20%
Rituximab
20%
Statistical Software
20%
Inflation Rate
20%
Significant Trend
20%
Imatinib
20%
Trastuzumab
20%
Price Increase
20%
Pemetrexed
20%
Medicare
20%
Rebates
20%
Average Sale
20%
State Department
20%
IBM SPSS Statistics
20%
Launch Costs
20%
US Inflation
20%
Department of Labor
20%
Neuroscience
Rituximab
100%
Imatinib
100%
Trastuzumab
100%
Pemetrexed
100%
Mathematics
Median
100%
Statistics
50%
Inflation Rate
50%
Medicine and Dentistry
Malignant Neoplasm
100%
Rituximab
20%
Imatinib
20%
Trastuzumab
20%
Pemetrexed
20%
Medicare
20%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Rituximab
20%
Imatinib
20%
Trastuzumab
20%
Pemetrexed
20%
Economics, Econometrics and Finance
Inflation
100%
Median
40%
Inflation Rate
20%